Found 6 matching trials
Effect of Exenatide LAR or Dulaglutide on the Variability of 24-hour Heart Rate and Blood Pressure in Type 2 Diabetes
PHASE4Mortality due to cardiovascular problems is increased by having Diabetes Me...
Location
Instituto de terapeutica Experimental y Clinica. Centro universitario de Ciencias de la Salud. Universidad de Guadalajara
Continuous Glucose Monitoring (CGM) in Subjects With Type 2 Diabetes Taking Twice-Daily Exenatide or Once-Weekly Exenatide
N/AThe purpose of this substudy is to obtain CGM data from individuals taking ...
Location
International Diabetes Center
Effects of Exenatide Long-Acting Release on Glucose Control and Safety in Subjects With Type 2 Diabetes Mellitus(DURATION - 1)
PHASE3A Randomized, Open-Label, Multicenter, Comparator-Controlled Study to Exami...
Location
Research Site 182
Efficacy of Exenatide-LAR and Dapagliflozin in Overweight/Obese, Insulin Treated Patients With Type 2 Diabetes
PHASE4The purpose of this study is to see what the effects of using one or two ad...
Location
Comprehensive Weight Control Center
Study Examining Exenatide Long-Acting Release in Subjects With Type 2 Diabetes
PHASE2Exenatide LAR is a long-acting release formulation of exenatide, which is a...
Long-acting Exenatide and Cognitive Decline in Dysglycemic Patients
PHASE3The overall objective of the study is to assess the potential effects of th...
Location
Endocrinology Unit